continu perform amid china headwind
updat forecast estim jan
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research jan
estim jan
price data apr
rate updat apr
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
think gdp-plu busi case plu
testament value-addit natur compani
product churn virtual inimit research
compani commit leverag innov across
dispar busi make worth sum
part commit manifest apportion
net sale expect continu
forecast firm earn gross profit
everi dollar spent forecast rel line
recent experi histor significantli greater
highli innov firm
portfolio
posit
faster-grow portion term industri well
geographi think healthcar segment gradual take
pivot role contribut firm revenu
oper incom mix particularli economi
geograph expos matur see segment rise
firm revenu end explicit
forecast one quarter oper
incom asid superior profit healthcar benefit
sever secular trend includ age popul rise chronic
diseas surgic procedur well demand effici
manag larg volum medic data also expect
outsiz growth safeti graphic segment driven
need replac age infrastructur increas urban
develop world therefor model top-lin
compound annual growth rate
also see slowli continu margin expans stori
believ firm make addit inroad preserv
competit cost posit undertak activ manageri effort
toward effici oper effort involv
increas share resourc cut raw materi cost
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
diversifi industri busi exist sinc
minnesota mine manufactur compani
known research develop prowess organ five
busi group industri safeti graphic healthcar electron
energi consum compani revenu come
outsid unit state industri segment constitut
plural firm net sale mani compani product
touch concern varieti consum industri
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
rais fair valu estim
primarili rais fair valu estim
due time valu money well new pension
time price-to-earnings multipl ep
estim versu time histor mean well
time enterpris value/ebitda multipl
time histor mean continu
believ stock fairli valu
believ increas revenu
compound annual growth rate model
top-lin assumpt project growth
firm subseg industri largest segment
net sale predominantli see growth come
abras adhes enjoy multipl applic
throughout firm abras growth driver includ
rapid expans intern automot product
along robust growth world-wide construct
industri safeti graphic next-largest segment
believ busi benefit person
safeti product busi high brand loyalti
expect global popul increasingli shift
live urban area well improv standard live
result demand build renov project
drive growth healthcar think signific
portion growth come medic consum
particularli dispos medic suppli driven
increas incid chronic diseas rise surgic
procedur across globe electron energi
see group benefit increas adopt
smartphon televis well increas need
energi effici
electr compon
consum see continu net sale growth nearli
per year averag base continu innov
see slight uptick margin medium term
driven lower manufactur cost sell gener
administr expens percentag net sale
base increas oper effici off-set slight
increas expens percentag net sale
stage ii model return new invest capit
growth match long-term
expect nomin global growth
assign low uncertainti rate given high
degre confid narrow rang potenti
intrins valu compani
bull-cas scenario fair valu estim rise
per share top-lin growth rise compound-annual-growth-rate
near top manag guidanc oper
margin improv basi point
level assumpt bull case relat
increment share gain oppos faster growth
market product portfolio expos base
assumpt strength firm portfolio
respons custom instanc firm
benefit addit exposur faster grow portion
specif healthcar also afford firm
addit oper profit
manag initi drive expand margin
includ addit benefit deriv region
platform well addit lean measur drive
oper effici return research capit rise
gross profit everi dollar
spent
bear-cas scenario fair valu estim drop
per share top-lin growth rise compound-annual-growth-rate
near bottom manag guidanc oper
margin compress toward bottom rang
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
includ patent brand proprietari technolog
firm spend net sale compar
median global innov
median diversifi industri firm mani
firm say innov yield invest
quantifi superior return research capit
outpac name top innov
compani name boston consult group everi
dollar spent yield gross
profit versu averag top case
even everi name list technolog sector
aggreg accord statista technolog
sector account nearli global spend
compar entir industri
sector three-year cycl return research capit
outpac firm top except bcg
number-on rank firm think testament
busi model place premium
effect commerci firm receiv
custom interact per year major
product develop cater specif custom input
oppos third-parti market insight custom
relationship difficult-to-repl intang asset
cultiv centuri worth oper
addit benefit effici elimin
program bear littl probabl commerci
altern acceler potenti
high impact high probabl success also
firm senior engin time unbudget
work new idea project independ
strong brand high share mind includ
scotch-brit ace bandag mani brand
command premium price exampl
standard yellow post-it note typic sell price
premium compar gener counterpart
recent histor perform assumpt
bear case relat increment share loss variou
categori product portfolio base increas
competit diminish brand equiti instanc
overal portfolio mix also less rich higher-grow
portion portfolio specif high-margin healthcar
effect competit manifest oper
margin forc spend acceler
pace rel net sale keep competitor bay
bear-cas scenario also assum mani manag
initi yield addit oper effici
bear case furthermor fail bear fruit final return
research capit fall gross profit
everi dollar spent
believ wide econom moat base
intang asset cost advantag diversifi
industri space think central
leverag core compet key build
endur competit advantag innov
powerhous maxim util platform
across multipl busi segment byproduct
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
believ consum will pay extra premium
associ product given reput
high qualiti overal firm steadili risen brand
valu recent year climb interbrand top
best global brand ahead
well-known brand like visa
product touch concern nearli everi
industri firm portfolio overli depend
singl product categori increas confid
long-run return invest capit
addit throughout histori firm benefit
global patent award accord
search patent trademark offic
award patent sinc
believ current patent portfolio exce carri
amount million list balanc sheet
account permit write
intang asset belief anchor firm proven
consist abil use asset gener excess
return think major
recent patent portfolio util patent
base data intellectu properti owner
associ qualifi design invent
must novel new non-obvi given compar
higher hurdl obtain util patent offer
advantag design patent given intellectu
properti protect around invent function
also protect mani differ variat product
singl approv file think complex
disrupt technolog reflect strength intang
asset moat sourc case microrepl
technolog use road sign grinder overhead
gross margin sale versu
median compar peer firm share resourc
provid economi scope abras
technolog affect industri construct
retail well automot
aftermarket collis repair firm adhes also
use wide rang applic scotch tape
post-it note tegaderm medic dress
emphasi region suppli chain reduc
complex manufactur process allow
shorter suppli chain fewer stock-keep unit
common process ultim translat diminish
demand work capit greater capit effici
drive unit cost improv custom experi
fewer back order cost custom servic
benefit amplifi common enterpris resourc
plan platform
function across suppli chain procur
addit benefit get
geograph proxim custom firm also
deriv economi scale manag suppli chain
across broader geographi vertic integr
firm manufactur mani raw materi lower
cost competitor moreov plant around
world anchor site time
larger typic plant larger plant
averag product smaller plant
tend drive inventori turn averag faster
phenomenon hold true firm distribut
center faster smaller local
technolog platform manufactur scale
allow achiev lowest unit cost
categori compet result enjoy
calcul period
achiev increment return tangibl asset
least past year return
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
includ benefit yield averag lean sigma
project averag lean project yield
benefit
aggreg compani deriv estim billion
save lean project think
testament effect lean sigma
program howev attribut margin benefit
process oper excel oppos firm
uniqu irreplac lean process
believ firm cost advantag moat sourc stabl
capit includ goodwil doubl
estim cost capit even year
compani endur neg sale growth even
worst year past year still manag earn
return includ goodwil clear weight
averag cost capit hurdl time
result high degre confid
continu produc excess return least next
view moat trend stabl quantit
five-year forecast adjust return invest capit
modestli line five-year histor adjust
return invest capit net
goodwil intang moat sourc firm
proprietari technolog continu support
consist spend approach
revenu sever year variou five-year cycl
return research capit rel constant
fluctuat gross profit everi
dollar spent difficult confirm believ
posit option moat-widen
opportun greater licens intellectu
properti particularli electron energi segment
lack organ revenu growth consist
segment compani past licens
certain ip around electron materi solut
licens deal offer advantag incur
addit cost ip develop thu
evid initi still see intang
moat sourc stabl
cost advantag moat sourc firm expand
gross oper margin recent year said
believ mani improv uniqu
admiss entir industri benefit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
continu emphas innov
spend percentag net sale total nearli
owhil earn return doubl
cost capit year firm struggl
gener fresh organ growth
oth firm continu benefit share
technolog platform develop product often
multipl use applic
custom prefer econom slowdown
like profit segment geographi
expos faster-grow portion global
allow easili earn goal
time growth industri product index
struggl attract retain best
brightest scientist engin natur
gravit toward technolog sector
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
view well capit debt
capit structur year-end carri
valu firm debt billion along
billion worth capit leas list balanc
sheet base calcul weight averag interest
rate remain year debt estim
present market valu debt closer billion
accord book valu amount billion
billion total carri valu debt
matur report net debt current
stand billion calcul assum
product revenu report cash
need oper busi use calcul market
valu debt calcul net debt closer billion
result view net debt/oper incom
time net debt/ebitda time
time think indic strength
balanc sheet firm plan ad increment
leverag billion billion support
capit alloc plan believ
manag increas debt load
expos sever risk view critic
risk compani would come form complac
pivot away commit innov
see sign risk come fruition although firm
decreas spend slightli percentag sale
think short-term issu relat mostli
time divestitur continu monitor
compani alloc capit still believ
manag remain deepli commit cultur
diminish brand power chang custom
prefer market accept new product
develop pipelin firm abil
risk believ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
find integr bolt-on acquisit supplement
organ revenu growth could affect revenu
assumpt plu minu well slow
growth china particularli given rel high
exposur asia-pacif region rel peer
overal sale firm numer on-
off-balance-sheet environmental/leg risk label
commit conting recent
settl environment suit earlier year home
state minnesota risk contagion
similar suit state think risk rel
immateri long run
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
chairman board/director/
repres date owner name posit common share held report holder issuer
fidel select envir alt engi port
capit research manag compani
fidel manag research compani
share
fund
share
fund
assign manag exemplari stewardship rate
michael roman becam ceo juli take
well-regard ing thulin
year capac chief oper offic execut
vice presid roman purview firm
intern oper well five busi
segment serv roman head
industri busi group thulin continu serv
execut chairman board
given roman comment electr product group
confer earli doubt materi pivot
playbook laid roadmap
particularli sinc intim involv
strateg plan process past roman
emphas growth organ invest
acquisit continu leverag insight around
critic custom product development-a strategi
like view recent re-affirmed
investor day roman present
specif mention build success sinc
like roman focus strateg
prioriti toward health safeti graphic
portion portfolio roman capit alloc
framework favor acquisit think
need augment organ growth provid
target price right one acquisit view
posit acquisit scott safeti roman
overseen integr busi gain
busi combin lead person safeti
reason behind exemplari stewardship rate
simpl first firm improv free cash flow convers
thulin instal
percent recent year even thulin increas
firm spend percentag net sale
tenur free cash flow eb
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
custom sustain final proven
leader field decades-long pollut
prevent program appreci emphasi
water reduct effort well reduc raw materi
landfil wast
overli concern expect bounc back head
next year -- expect convers equal
averag go forward plu minu year
year second import manag
increas firm pay-out ratio begin
tenur left roman
continu pay gener dividend pay-out ratio
earn top end rang
multi-industri peer typic pay
appreci oper steadi
low-growth industri prefer return capit
sharehold overpay acquisit buy back
share
exampl
instanc prefer manag pay
aggress monitor cost go far cancel
firm annual meet product expo interest
sharehold also appreci thulin commit
preserv polici unalloc
assign senior engin well
reluct impos much process cost
innov believ commit remain
steadfast firm roman leadership
less attract price
compani leadership thulin wise emphas
sustain view treat opportun
oppos threat think firm well
posit capit increas paradigm shift
particularli mani solut align well esg
prioriti mani technolog develop
electron energi segment could benefit firm
stakehold trend toward green
solut exampl includ firm filtrat initi
use low-foul membran also note
compani commit sustain health
summit share best practic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
thesi wide-moat rate remain intact
firm continu perform expect jan
wide-moat rate decent fourth quarter
broadli line fourth-quart full-year
expect roll model forward anticip
modestli rais fair valu estim base
mostli time valu money new pension
assumpt leav long-run expect
rel intact may make addit minor
chang firm releas annual report
sub-seg inform even retain
wide-moat low uncertainti stabl trend exemplari
report full-year sale billion versu
expect billion growth year
year organ local-curr basi ep
also modestli line expect
full year compar estim adjust
net tax expens cent per share after-tax
expens relat first-quart legal settlement
adjust ep year came current
gaap ep expect prior announc result
come compar manag current
guidanc midpoint
manag expect larg proport
improv full-year result come
organ sale growth portfolio manag base
manag commentari call expect
major organ sale growth back-end load
particularli given tougher first-half comp
note free cash flow convers dip year
rel prior four year compar
rang overli concern
expect improv hover around next
year remain one highest qualiti diversifi
industri coverag term free cash flow
convers free cash flow divid net incom
turn segment coupl item stood
us health return strong perform quarter
organ sale year year quarter
sale health grew multipl sub-seg
solut even oral care laggard
earlier part year drug deliveri continu
declin expect growth volatil given
project-bas natur busi expect
continu see growth flow
acquisit modal technolog busi safeti
graphic tradit strong perform saw
organ growth year year quarter one
item found interest acquisit
scott safeti perform well growth double-
digit base manag dialogu analyst tyco
never abl achiev type growth unit
ceo mike roman tout win combin
two team specif term person safeti
portfolio well project theyv pick
recent nice tailwind electron energi
nice quarter sale particularli strong
survey firm result manag
commentari believ thesi remain intact weve
consist believ growth
portfolio driven safeti
graphic given long-term secular trend drive
urban develop world need updat
age infrastructur grow awar worker-
relat safeti relat regul age popul
risk increas chronic ill like diabet
asthma surgic procedur well need
manag larg amount health data one item well
continu monitor slow growth china particularli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
given geograph exposur asia-pacif region
typic revenu given year return
research capit current year gross profit divid prior
year spend dip slightli year compar
prior-year result line
expect year importantli
long-term expect continu believ
high-qual well-run compani believ
market adequ apprais futur earn potenti
latest acquisit may give firm stronger
foot help improv patient outcom dec
wide-moat announc agre acquir
technolog busi modal deal valu
enterpris valu billion time adjust annual
ebitda month follow transact
market react neg deal possibl due
deal dilut ep next year accord
expect synergi time multipl seem
rel line three public peer compar
deal modal privat compani
revenu growth assumpt
deal exclud modal transcrib
code busi also seem strateg fit
health inform system busi given target
emphasi artifici intellig technolog alreadi
exist clinic document softwar risk
assess system captur analyz patient data
caretak maintain fair
valu estim get detail deal
presum new year
health care segment lag expect
recent still anticip top-lin organ
growth five-year explicit forecast
said segment perform softli back-
half year busi line like oral care
lag variou point weve surpris
overli concern event innov
innov come pocket volatil exampl
drug deliveri one busi line short-term
gyrat expect investor believ
stock simpli trade level line
firm recent econom realiti
even still like emphasi healthcar space
believ afford opportun addit
greater-than-gdp growth still believ health care
safeti graphic segment engin
drive growth firm portfolio sever
secular trend believ well-posit
capit includ age popul increas
incid chronic diseas larg amount medic
data also call effici manag mean
analyz data point investor
day firm signific scale across hospit
touch million health record month
think deal complement exist portfolio
introduc convers ai softwar physician
improv patient outcom yield uniqu medic
insight cut medic cost may move
risk curv like firm long-term
think particularli sinc value-bas outcom
increas import futur
wide moat-rat report disappoint result
third quarter alter long-term
fundament outlook firm result dont
expect materi chang fair valu estim
firm improv third-quart organ sale year
year year year report basi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
tough comp last year third quarter rose
year year sale also tough sequenti comp
last quarter enterpris resourc plan system
saw sale front
load base custom
anticip roll said third quarter free
cash flow rose year year free cash flow
convers impress allow
return million sharehold form dividend
well billion form share repurchas
look close
oper segment
perform bit tale two citi thesi
larg depend overal portfolio manag
expect safeti graphic healthcar
deliv portfolio growth safeti graphic
bright spot firm organ sale
grew year year acquisit scott safeti
strong growth engin exceed
year year even neg year-over-year
healthcar howev advers headwind
revenu decreas year year healthcar
run manag sale growth
target segment overli concern
near-term weak healthcar segment
weak attribut firm
drug deliveri busi well tough comp last
year rose year year
investor recal question manag
last quarter earn call focus busi line
manag explain drug deliveri project-bas
busi tie pharmaceut industri
regulatori cycl found answer convinc
past continu encouragingli manag still
see strong pipelin ahead look forward
updat project pipelin investor day next
month expect pulmonari drug deliveri system
continu grow respiratori diseas rise
around globe
growth acquir scott safeti import
certain busi line seen strong
headwind like roof granul declin midteen
shingl manufactur slow product quarter
also offset weak firm transport
safeti busi grew midsingl digit ahead
expect
turn firm region firm emea busi
fallen recent call manag report
industri auto build rate soften bit
slowdown across western europ growth track
low-singl digit bottom end project rang
one item perk ear call
upcom slowdown chines respiratori protect
space well slow automot build rate move
forward look item particularli
view person safeti busi import
compon long-term growth trajectori
final firm lower top-lin growth ep
full year guidanc manag expect free cash
flow convers full year run firm
five-year histor perform despit
quarter out-performance
lower
expect year quarter perform
doubt make difficult manag fulfil exist
sale earn expect year said
think firm share price declin nearli morn
write overreact firm latest
result bottom sell side price
target rang fair valu estim simpli
believ market expect divorc
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
realist growth assumpt address market
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
